CPRX
Catalyst Pharmaceuticals Inc
NASDAQ: CPRX · HEALTHCARE · BIOTECHNOLOGY
$28.26
-4.01% today
Updated 2026-04-29
Market cap
$3.45B
P/E ratio
16.82
P/S ratio
5.86x
EPS (TTM)
$1.68
Dividend yield
—
52W range
$19 – $33
Volume
1.5M
Catalyst Pharmaceuticals Inc (CPRX) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
8 of 8
Last 8 quarters
Avg EPS surprise
+48.2%
Last 4 quarters
Revenue YoY growth
+7.6%
Most recent quarter
EPS YoY growth
+54.5%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-5.9%
Last 3 reports
Positive reaction rate
0%
0 of 3 quarters
Largest single-day move
-11.6%
2025-08-06
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-18 | $0.68 | +128.2% | $23.33 | $22.33 | -4.3% |
| 2025-11-05 | $0.42 | +27.3% | $21.34 | $20.99 | -1.6% |
| 2025-08-06 | $0.41 | +5.1% | $22.22 | $19.64 | -11.6% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $0.30 | $0.68 | +128.2% | $152.61M | +7.6% |
| 2025-09-30 | $0.33 | $0.42 | +27.3% | $148.39M | +15.3% |
| 2025-06-30 | $0.39 | $0.41 | +5.1% | $146.56M | +19.4% |
| 2025-03-31 | $0.34 | $0.45 | +32.4% | $141.42M | +43.6% |
| 2024-12-31 | $0.32 | $0.44 | +37.5% | $141.82M | +28.3% |
| 2024-09-30 | $0.30 | $0.35 | +16.7% | $128.69M | +25.3% |
| 2024-06-30 | $0.26 | $0.33 | +26.9% | $122.71M | +23.2% |
| 2024-03-31 | $0.17 | $0.19 | +11.8% | $98.51M | +15.4% |
| 2023-12-31 | $0.27 | $0.31 | +14.8% | $110.57M | — |
| 2023-09-30 | $-0.28 | $-0.29 | -3.6% | $102.69M | — |
| 2023-06-30 | $0.42 | $0.53 | +26.2% | $99.58M | — |
| 2023-03-31 | $0.32 | $0.26 | -18.8% | $85.37M | — |
Frequently asked questions
Has Catalyst Pharmaceuticals Inc beaten earnings estimates?
Catalyst Pharmaceuticals Inc has beaten Wall Street EPS estimates in 8 of its last 8 quarterly reports, with an average EPS surprise of +48.2% over the last 4 quarters.
How does CPRX stock react to earnings?
CPRX stock has moved an average of -5.9% in the trading day following earnings over its last 3 reports, with positive reactions in 0% of those quarters.
What is Catalyst Pharmaceuticals Inc's revenue growth rate?
Catalyst Pharmaceuticals Inc reported year-over-year revenue growth of +7.6% in its most recent quarter, with EPS growing +54.5% year-over-year.